Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Statistical considerations in biosimilar assessment using biosimilarity index

In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation

View More »

Google Scholar citation report
Citations : 4363

Journal of Bioequivalence & Bioavailability received 4363 citations as per Google Scholar report

Flyer image
Journal of Bioequivalence & Bioavailability peer review process verified at publons
Flyer image
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Flyer image
Open Access Journals
View More

Kiran K Vangara

Kiran K Vangara

Research and Development, Insys Therapeutics. Inc., Chandler, AZ

Biography
Dr. Vangara is currently working as a Group Leader-Formulation at Insys Therapeutics, Inc at Chandler, AZ. He received his PhD in Pharmaceutics from Texas A&M Health Science Center, College Station, TX. He received Masters in Pharmaceutics and Bachelors in Pharmacy from Kakatiya University, India.
Research Interest
Solubility and Bioavailability Enhancement, Liquid or Softgel capsule Formulations, Novel Drug Delivery Systems, and Targeted Drug Delivery.